3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Smoldering Multiple Myeloma
1
Polyps
1
Peripheral Nervous System Diseases
1
Monoclonal Gammopathy of Undetermined Significance
1
Malnutrition
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Dyspareunia
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Interventions
eicosapentaenoic acid ethyl ester
1
Ofloxacin
1
Fatty Acids, Omega-3
1
Everolimus
1
Doxycycline
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Polyps
×
Fatty Acids, Omega-3
×
Clear all
NCT03661047
2021-11-17
OMICC
Massachusetts General Hospital
Phase 2
Withdrawn